Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

tRNA-Histidine Guanylyltransferase 1-Like (THG1L) (Middle Region) Peptide

THG1L Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5673680

Quick Overview for tRNA-Histidine Guanylyltransferase 1-Like (THG1L) (Middle Region) Peptide (ABIN5673680)

Target

THG1L (tRNA-Histidine Guanylyltransferase 1-Like (THG1L))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    DGRVVVYPSN QTLKDYLSWR QADCHINNLY NTVFWALIQQ SGLTPVQAQG

    Characteristics

    This is a synthetic peptide designed for use in combination with anti- THG1L Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    THG1L (tRNA-Histidine Guanylyltransferase 1-Like (THG1L))

    Background

    The protein encoded by this gene is a mitochondrial protein that is induced by high levels of glucose and is associated with diabetic nephropathy. The encoded protein appears to increase mitochondrial biogenesis, which could lead to renal fibrosis. Another function of this protein is that of a guanyltransferase, adding GMP to the 5' end of tRNA(His). Several transcript variants encoding different isoforms have been found for this gene.

    Alias Symbols: ICF45, IHG-1, hTHG1

    Protein Size: 298

    Gene ID

    54974

    NCBI Accession

    NM_017872, NP_060342

    UniProt

    Q9NWX6
You are here:
Chat with us!